Ascendis Pharma A/S (ASND)
236.00
-5.38
(-2.23%)
USD |
NASDAQ |
Mar 05, 13:03
Ascendis Pharma Cash from Investing (TTM) : -9.612M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Novo Nordisk A/S | -12.02B |
| Evaxion AS | -- |
| DBV Technologies SA | 0.1363M |
| Cellectis SA | -68.81M |
| Biodexa Pharmaceuticals Plc | -0.4065M |